CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)
 
     
 
 
 
Medifast, Inc. Company Snapshot
Business Description:
Medifast, Inc. operates in the Pharmaceutical preparations sector. Medifast, Inc. (Medifast) is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. The product lines include weight and disease management, meal replacement, and vitamins. The Company offers a range of weight and disease management products under the Medifast and Essential brand and for select private label customers. The Medifast line includes Medifast 55 Shakes, Medifast 70 Shakes, Medifast Plus for Appetite Suppression Shakes, Medifast Plus for Women's Health Shakes, Medifast Plus for Diabetics Shakes, Medifast Plus for Joint Health Shakes, Medifast Plus for Coronary Health Shakes and Essential 1 Calorie Burn Drinks. The Company's operations are primarily conducted through five of its wholly owned subsidiaries: Jason Pharmaceuticals, Inc. (Jason), Take Shape for Life, Inc. (TSFL), Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. In our complete report available for purchase the company is compared to: Emergent BioSolutions, Inc., K-V Pharmaceutical Company and Auxilium Pharmaceuticals, Incorporation.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Medifast, Inc.
  Stock Performance Chart for Medifast, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 16.32
(Figures in U.S. Dollars)
1 Week -0.8%   13 Weeks 6.3%  
4 Weeks 8.7%   52 Weeks -32.9%  
 
Medifast, Inc. Key Data:
  Ticker: MED Country: UNITED STATES
  Exchanges: NYSE Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Diversified Drugs, Cosmetics, & Health Care
  2010 Sales 257,552,000
(Year Ending Jan 2011).
Employees: 507
  Currency: U.S. Dollars Market Cap: 252,147,019
  Fiscal Yr Ends: December Shares Outstanding: 15,450,185
  Share Type: Common Closely Held Shares: 1,658,085
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.